Our Research

Leeds BRC has a broad portfolio of translational research in musculoskeletal disease. This is focussed on developing early identification and early stratified intervention with the aim of:

  • Preventing disease and disability in immune-mediated inflammatory diseases (through preclinical diagnosis and prevention, disease phenotyping and precise delivery of targeted therapy)
  • Improving the treatment for osteoarthritis, enabling “50 active years after 50” (through molecular/physical therapy, autologous stem cells, acellular scaffolds and joint replacement)

Our Research Themes and Workstreams

Our research is undertaken through the following two Research Themes and seven Workstreams:

  • Optimal treatment and preventing disability in immune-mediated inflammatory diseases (Workstream one to four)
  • Improving the treatment of osteoarthritis (Workstream five to seven)